Download presentation
Presentation is loading. Please wait.
Published byEstefania Moya Modified over 5 years ago
1
By Dr. Satti Abdulrahim Satti Consultant Pediatrician
بسم الله الرحمن الرحيم Measles By Dr. Satti Abdulrahim Satti Consultant Pediatrician
2
Called Rubeola . An acute viral infection. Measles virus is : An RNA virus Only one serotype.
3
Epidemiology & Pathogenesis
Rarely subclinical . No animal reservoir. Highly contagious . Mainly by droplet spray during catarrhal stage . Infants acquire immunity transplacentally.
4
Hyperplasia of lymphoid tissue.
Hecht giant cell pneumonia. Encephalomyelitis & Subacute Sclerosing Panencephalitis ( SSPE )
5
Clinical Manifestations
Three clinical stages : Incubation , Prodromal & Final stage. Incubation phase : IP is d. Prodromal phase : !! Very ill pts . !! Fever, Cough & Coryza.
6
!! A transverse conjunctivitis with Photophobia .
!! Koplik spots . !! Red mottling on palates. !! Lasts 3-5 days .
7
Final stage : !! The Rash * Maculopapular . * Starts up then spreads down till reach feet. * It fades downwards. * Often Hgic . Petechiae & ecchymosis may appear. * Itching is slight.
9
Koplik spots & Measles rash on face
11
!! Desquamation & brownish discoloration.
!! Black measles = Hgic type. With bleeding. !! ↑ Lymph nodes & Spleenomegaly. !! Abdominal pain . !! V & D, Bronchopneumonia & Otitis media . !! Appendicitis.
12
Measles desquamation Staining in measles
13
Complications Otitis Media . Laryngitis .
Pneumonia (Bacterial or Giant cell p.) Exacerbation of underlying tuberculous infection . Myocarditis . Disseminated Intravascular coagulation ( DIC )
14
. Neurologic complications:
* Encephalitis (Direct viral invasion or demylinating) * Guillain-Barre` synd. * Hemiplegia . * S S P E .
15
Diagnosis Clinically (The rash & ? Koplik spots) Measles IgM Abs
Isolation of measles virus (by culture) Leucopenia . CSF : ↑ Lymphocytes. ↑ Protein . Normal Glucose.
16
Differential Diagnosis
German measles (Rubella) Roseola infantum (HHV6) Infectious Mononucleosis. Scarlet fever . Kawasaki disease. Drug rash .
17
Treatment Mainly supportive.
Hospitalization for treatment of complications . Bed rest . Standard Antipyretics is appropriate.
18
Humidified air . Maintenance of good hydration & replacement of fluids lost through diarrhea or emesis . Antibiotics for bacterial complications.
19
Vitamin A Supplementation
!! Lead to 50% reductions in morbidity & mortality and help prevent eye damage and blindness. !! Supplementation is as follows: * < 6 months – 50,000 IU/day PO for 2 doses * months - 100,000 IU/day PO for 2 doses * Older than 1 year - 200,000 IU/day PO for 2 doses
20
Children with clinical signs of vitamin A deficiency :
* Children with clinical signs of vitamin A deficiency : ! First 2 doses as appropriate for age. ! Then a third age-specific dose given 2-4 weeks later.
21
Prevention Isolation : From 7th d. after exposure until 5 d after rash has appeared. Susceptible health care workers should be excused from work from the fifth to the 21st day after exposure.
22
! It is given to the following individuals:
! Human Ig prevents or modifies disease in susceptible contacts if given within 6 days of exposure. ! It is given to the following individuals: * Those who are immunocompromised. * Infants aged 6 months to 1 year. * Infants younger than 6 months who are born to mothers without measles immunity. * Pregnant women.
23
Measles Vaccine : ! As MMR : ! Given IM . ! Kept in the freezer. ! Destroyed by light . ! At mo age.
24
! 2nd dose at 18 month of age. ! Contraindicated in :
! At 9 month in developing countries. ! 2nd dose at 18 month of age. ! Contraindicated in : Untreated tuberculosis, Primary immunodeficiency, Organ transplantation or severe HIV infection. ♣♣♣ ♣
25
Thank You All
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.